Logo Logo
Hilfe
Hilfe
Switch Language to English

Kapetanios, Dimitrios ORCID logoORCID: https://orcid.org/0000-0002-1747-0610; Czihal, Michael ORCID logoORCID: https://orcid.org/0000-0003-4199-6345; Tsilimparis, Nikolaos ORCID logoORCID: https://orcid.org/0000-0002-6313-7595; Torsello, Giovanni ORCID logoORCID: https://orcid.org/0000-0001-7513-5063; Rieck, Julian und Stavroulakis, Konstantinos ORCID logoORCID: https://orcid.org/0000-0002-9775-9210 (2024): Intravascular lithotripsy-assisted percutaneous deep vein arterialization for no-option chronic limb-threatening patients and heavily calcified tibial occlusive disease. In: Vascular [Forthcoming]

Volltext auf 'Open Access LMU' nicht verfügbar.

Abstract

Purpose: To report the first chronic limb-threatening ischemia (CLTI) patients who underwent an intravascular lithotripsy (IVL)-assisted percutaneous deep vein arterialization (pDVA). Case Report 1: An 81-year-old patient presented with CLTI and a heavily calcified lesion of the popliteal artery and tibioperoneal trunk (TPT), with a distal tibial and foot arch occlusion. The patient underwent IVL and drug-coated balloon angioplasty for the distal popliteal artery and of the TPT to improve the inflow prior to pDVA. The wound situation remained stable without secondary procedure until the patient`s deaths due to complications of urosepsis 3 months later. Case Report 2: A 64-year-old patient with rest pain of the left limb with a single-vessel tibial run-off (peroneal artery) and occluded pedal arch was treated with 3.5 mm IVL followed by a successful pDVA as mentioned above. IVL performed in the proximal posterior tibial artery to optimize the inflow to the circuit and change the compliance of the crossing point from the arterial to the vein system. The patient underwent repeat angioplasty of the plantar vein arch 5 months after the index procedure and thereafter remained asymptomatic during 2 years of follow-up. Conclusion: The combined use of IVL and pDVA could improve the patency of the reconstruction with clinical benefits in no-option CTLI patients.

Dokument bearbeiten Dokument bearbeiten